INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 130 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,684 | -19.7% | 53,129 | +6.3% | 0.00% | -20.0% |
| Q2 2023 | $2,096 | +18.4% | 50,000 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $1,771 | +27.5% | 50,000 | +25.0% | 0.00% | 0.0% |
| Q4 2022 | $1,389 | -99.9% | 40,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $2,175,000 | +27.9% | 40,000 | +21.2% | 0.01% | +20.0% |
| Q2 2022 | $1,700,000 | -25.7% | 33,000 | +4.1% | 0.01% | -16.7% |
| Q1 2022 | $2,288,000 | -22.3% | 31,700 | +26.3% | 0.01% | -14.3% |
| Q4 2021 | $2,944,000 | -12.0% | 25,100 | +2.4% | 0.01% | -22.2% |
| Q3 2021 | $3,346,000 | -14.3% | 24,500 | 0.0% | 0.01% | -18.2% |
| Q2 2021 | $3,905,000 | +99.8% | 24,500 | -7.5% | 0.01% | +83.3% |
| Q1 2021 | $1,954,000 | +91.2% | 26,500 | +41.0% | 0.01% | +50.0% |
| Q4 2020 | $1,022,000 | +205.1% | 18,800 | +19.7% | 0.00% | +300.0% |
| Q3 2020 | $335,000 | -32.5% | 15,700 | -51.8% | 0.00% | -50.0% |
| Q2 2019 | $496,000 | -20.5% | 32,600 | +63.0% | 0.00% | -50.0% |
| Q1 2019 | $624,000 | +212.0% | 20,000 | +22.7% | 0.00% | +300.0% |
| Q4 2018 | $200,000 | -67.9% | 16,300 | -18.5% | 0.00% | -75.0% |
| Q3 2018 | $624,000 | -31.0% | 20,000 | -40.3% | 0.00% | -33.3% |
| Q2 2018 | $905,000 | +40.3% | 33,500 | +9.8% | 0.01% | +50.0% |
| Q1 2018 | $645,000 | +748.7% | 30,500 | +563.0% | 0.00% | +300.0% |
| Q4 2017 | $76,000 | 0.0% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $76,000 | +1.3% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $75,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |